Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/30/23 08:36 | 5/25/23 | NSTG | Health | BioPrd | Biological Products, (No Diag | Gray R Bradley | WA | DO | P,CEO | 1 | P | 174 | 5.80 | 0 | 30 | 10 | 338 | D | ||||||||||||||
5/30/23 08:36 | 5/26/23 | NSTG | Health | BioPrd | Biological Products, (No Diag | Bailey K Thomas | WA | O | CFO | 1 | P | 86 | 5.76 | 0 | 15 | 25 | 75 | D | ||||||||||||||
5/26/23 08:41 | 5/24/23 | NSTG | Health | BioPrd | Biological Products, (No Diag | Young William | WA | D | 1 | P | 202 | 5.69 | 0 | 35 | 313 | 47 | D | |||||||||||||||
3/14/23 16:41 | 3/13/23 | NSTG | Health | BioPrd | Biological Products, (No Diag | Waite Charles P Jr | WA | D | 1 | P | 100 | 8.35 | 0 | 12 | 106 | 23 | D | |||||||||||||||
3/8/23 16:08 | 3/7/23 | NSTG | Health | BioPrd | Biological Products, (No Diag | Norden Gregory | WA | D | 1 | P | 123 | 9.84 | 0 | 13 | 111 | 24 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |